Search Results - "Gadaleta, C D"
-
1
Sorafenib (BAY 43-9006) in hepatocellular carcinoma patients: from discovery to clinical development
Published in Current medicinal chemistry (01-03-2012)“…Angiogenesis and signaling through the RAS/RAF/mitogen-activated protein/extracellular signal-regulated kinase (ERK) kinase (MEK)/ERK cascade have been…”
Get more information
Journal Article -
2
mTOR as a target of everolimus in refractory/relapsed Hodgkin lymphoma
Published in Current medicinal chemistry (01-03-2012)“…Despite impressive treatment advances, few options for refractory or relapsed Hodgkin Lymphoma (HL) are available and there is a need for new compounds…”
Get more information
Journal Article -
3
VEGF concentration from plasma‐activated platelets rich correlates with microvascular density and grading in canine mast cell tumour spontaneous model
Published in Journal of cellular and molecular medicine (01-03-2009)“…Canine cutaneous mast cell tumour (CMCT) is a common cutaneous tumour in dog, with a higher incidence than in human. CMCT is classified in three subgroups,…”
Get full text
Journal Article -
4
A model of study for human cancer: Spontaneous occurring tumors in dogs. Biological features and translation for new anticancer therapies
Published in Critical reviews in oncology/hematology (01-10-2013)“…Abstract Murine cancer models have been extremely useful for analyzing the biology of pathways involved in cancer initiation, promotion, and progression…”
Get full text
Journal Article -
5
Chymase-positive Mast cells correlate with tumor angiogenesis: first report in pancreatic cancer patients
Published in European review for medical and pharmacological sciences (01-11-2021)“…Mast cells (MCs) are known to be involved in several physiological and pathological processes in humans and animals. Recently, their potential role in tumor…”
Get more information
Journal Article -
6
A modified cell block technique for fine needle aspiration cytology
Published in Acta cytologica (01-01-1995)“…A modification of the cell block technique, useful in processing material obtained by fine needle aspiration (FNA), is described. Four hundred six aspirates,…”
Get more information
Journal Article -
7
TEMPORARY REMOVAL: PO-63: Edoxaban effect in a breast cancer patient with liver arterial infusion chemotherapy (LAIC) and both jugular vein and hepatic artery thrombosis: a unique clinical case
Published in Thrombosis research (01-05-2022)“…The publisher regrets that this article has been temporarily removed. A replacement will appear as soon as possible in which the reason for the removal of the…”
Get full text
Journal Article -
8
Mast cells positive to Tryptase correlates with protease-activated receptor-2 expression and microvascular density in breast cancer patients
Published in BMC geriatrics (27-08-2010)Get full text
Journal Article -
9
Hypoxic stop-flow perfusion with mitomycin-C in the treatment of multifocal liver metastases. Usefulness of a vascular arterial stent to prevent iatrogenic lesions of the hepatic arterial wall
Published in Journal of experimental & clinical cancer research (01-12-2003)“…13 patients affected by multifocal and/or large liver metastases from various solid tumors have been treated with stop-flow liver perfusion, to evaluate the…”
Get more information
Journal Article -
10
Mast Cells Density Positive to Tryptase Correlate with Microvascular Density in both Primary Gastric Cancer Tissue and Loco-Regional Lymph Node Metastases from Patients That Have Undergone Radical Surgery
Published in International journal of molecular sciences (15-11-2016)“…Mast Cells (MCs) play a role in immune responses and more recently MCs have been involved in tumoral angiogenesis. In particular MCs can release tryptase, a…”
Get full text
Journal Article -
11
Tryptase-positive mast cells correlate with angiogenesis in early breast cancer patients
Published in International journal of oncology (01-07-2009)“…Literature data indicate that mast cells (MCs) are involved in tumor angiogenesis due to the release of several pro-angiogenetic factors among which tryptase,…”
Get full text
Journal Article -
12
Segmental pulmonary arterial chemoembolization with drug-eluting beads combined with radiofrequency thermal ablation for lung malignancies: A pilot study in 16 cases
Published in Journal of clinical oncology (20-05-2011)“…Abstract only…”
Get full text
Journal Article -
13
Serum tryptase evaluation in HCC patients who underwent transarterial chemoembolization
Published in Journal of clinical oncology (20-05-2011)“…Abstract only…”
Get full text
Journal Article -
14
Lung RFA: Long-term results in a single-center experience
Published in Journal of clinical oncology (20-05-2008)“…Abstract only…”
Get full text
Journal Article -
15
Platelts VEGF concentantions in healthy controls volunteers and HCC patients submitted to percutaneously radiofrequency thermal ablation
Published in Journal of clinical oncology (20-05-2008)“…Abstract only…”
Get full text
Journal Article -
16
Phase II trial of nemorubicin hydrocloride (nemorubicin) in combination with cisplatin (cDDP) in patients (pts) with hepatocellular carcinoma (HCC): First step results
Published in Journal of clinical oncology (20-05-2009)“…Abstract only 4593 Background: Nemorubicin is a novel DNA-intercalator, mainly metabolized in liver by CYP3A4 enzyme and showing synergic antitumor activity…”
Get full text
Journal Article -
17
Mast cell tryptase density correlates to angiogenesis in female breast cancer patients
Published in Journal of clinical oncology (20-05-2008)“…Abstract only…”
Get full text
Journal Article -
18
Platelts VEGF concentrations in healthy controls volunteers and HCC patients submitted to percutaneously radiofrequency thermal ablation
Published in Journal of clinical oncology (20-05-2008)“…Abstract only…”
Get full text
Journal Article -
19
Nemorubicin hydrochloride (nemorubicin) in combination with cisplatin (cDDP): Phase I in patients (pts) with hepatocellular carcinoma (HCC)
Published in Journal of clinical oncology (20-05-2008)“…Abstract only…”
Get full text
Journal Article -
20
P2-05-03: Is Breast Cancer Tryptase a Novel Anti-Angiogenetic Molecular Target?
Published in Cancer research (Chicago, Ill.) (15-12-2011)“…Abstract Tryptase, a serine protease stored and released from mast cells granules has been identified as a new non-classical angiogenetic factor. Tryptase is…”
Get full text
Journal Article